Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|
January 10, 2020
Correction to: Developing vaccines against epidemic-prone emerging infectious diseases
Valentina Bernasconi, Paul A Kristiansen, Mike Whelan, et al.
NPJ Vaccines
|
August 1, 2025
How Rwanda mounted a research response with an investigational vaccine just ten days into a Marburg outbreak
Sabin Nsanzimana, Noella Bigirimana, Richard Hatchett, et al.
BMJ Open
|
March 9, 2022
Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo
Deborah Watson-Jones, Hugo Kavunga-Membo, Rebecca F Grais, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
February 19, 2026
Vaccines and antimicrobial resistance: from science to policy-summary and outcomes
Calman A MacLennan, Mateusz Hasso-Agopsowicz, Kelvin M Abuga, et al.
Disaster Medicine and Public Health Preparedness
|
June 18, 2019
Chemical, Biological, Radiological, Nuclear, and Explosive (CBRNE) Science and the CBRNE Science Medical Operations Science Support Expert (CMOSSE)
C Norman Coleman, Judith L Bader, John F Koerner, et al.
Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science
|
December 19, 2012
Medical planning and response for a nuclear detonation: a practical guide
C Norman Coleman, Steven Adams, Carl Adrianopoli, et al.
The New England Journal of Medicine
|
September 10, 2025
Marburg Virus Disease in Rwanda, 2024 - Public Health and Clinical Responses
Sabin Nsanzimana, Eric Remera, Menelas Nkeshimana, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|
January 10, 2020
Correction to: Developing vaccines against epidemic-prone emerging infectious diseases
Valentina Bernasconi, Paul A Kristiansen, Mike Whelan, et al.
NPJ Vaccines
|
August 1, 2025
How Rwanda mounted a research response with an investigational vaccine just ten days into a Marburg outbreak
Sabin Nsanzimana, Noella Bigirimana, Richard Hatchett, et al.
BMJ Open
|
March 9, 2022
Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo
Deborah Watson-Jones, Hugo Kavunga-Membo, Rebecca F Grais, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
February 19, 2026
Vaccines and antimicrobial resistance: from science to policy-summary and outcomes
Calman A MacLennan, Mateusz Hasso-Agopsowicz, Kelvin M Abuga, et al.
Disaster Medicine and Public Health Preparedness
|
June 18, 2019
Chemical, Biological, Radiological, Nuclear, and Explosive (CBRNE) Science and the CBRNE Science Medical Operations Science Support Expert (CMOSSE)
C Norman Coleman, Judith L Bader, John F Koerner, et al.
Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science
|
December 19, 2012
Medical planning and response for a nuclear detonation: a practical guide
C Norman Coleman, Steven Adams, Carl Adrianopoli, et al.
The New England Journal of Medicine
|
September 10, 2025
Marburg Virus Disease in Rwanda, 2024 - Public Health and Clinical Responses
Sabin Nsanzimana, Eric Remera, Menelas Nkeshimana, et al.
Page
of 4